Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
PLoS One
2014 Feb 19;92:e87964. doi: 10.1371/journal.pone.0087964.
Show Gene links
Show Anatomy links
Generation of recombinant antibodies to rat GABAA receptor subunits by affinity selection on synthetic peptides.
Koduvayur SP, Gussin HA, Parthasarathy R, Hao Z, Kay BK, Pepperberg DR.
???displayArticle.abstract???
The abundance and physiological importance of GABAA receptors in the central nervous system make this neurotransmitter receptor an attractive target for localizing diagnostic and therapeutic biomolecules. GABAA receptors are expressed within the retina and mediate synaptic signaling at multiple stages of the visual process. To generate monoclonal affinity reagents that can specifically recognize GABAA receptor subunits, we screened two bacteriophage M13 libraries, which displayed human scFvs, by affinity selection with synthetic peptides predicted to correspond to extracellular regions of the rat α1 and β2 GABAA subunits. We isolated three anti-β2 and one anti-α1 subunit specific scFvs. Fluorescence polarization measurements revealed all four scFvs to have low micromolar affinities with their cognate peptide targets. The scFvs were capable of detecting fully folded GABAA receptors heterologously expressed by Xenopus laevis oocytes, while preserving ligand-gated channel activity. Moreover, A10, the anti-α1 subunit-specific scFv, was capable of detecting native GABAA receptors in the mouse retina, as observed by immunofluorescence staining. In order to improve their apparent affinity via avidity, we dimerized the A10 scFv by fusing it to the Fc portion of the IgG. The resulting scFv-Fc construct had a Kd of ∼26 nM, which corresponds to an approximately 135-fold improvement in binding, and a lower detection limit in dot blots, compared to the monomeric scFv. These results strongly support the use of peptides as targets for generating affinity reagents to membrane proteins and encourage investigation of molecular conjugates that use scFvs as anchoring components to localize reagents of interest at GABAA receptors of retina and other neural tissues, for studies of receptor activation and subunit structure.
???displayArticle.pubmedLink???
24586298 ???displayArticle.pmcLink???PMC3929611 ???displayArticle.link???PLoS One ???displayArticle.grants???[+]
Figure 2. Binding affinities of anti-α1 and β2 scFvs measured using fluorescence polarization.Purified scFv proteins were incubated with 6 or 4 µM (α1 or β2, respectively), of FITC-conjugated target peptide. Changes in polarization were measured in millipolarization (mP) units and plotted against concentration of the scFv. The Kd value of one representative trial is shown. Error bars correspond to standard deviations for duplicate measurements.
Figure 3. Immunofluorescence staining of GABAA receptors expressed in Xenopus laevis oocytes.X. laevis oocytes were injected with 50 nL of GABAA receptor mRNA (A) or buffer (B), and later incubated with 70 nM anti-α1 (A10) and 100 nM β2 (A7, G8, G11) scFvs, and binding of the scFvs to the cell surfaces was detected with a mouse anti-Flag antibody conjugated to FITC. Representative images are shown for each condition; four independent replicates were performed for each condition. Scale bar depicts 150 µm.
Figure 4. Binding of scFvs to native GABA receptors in mouse retinal sections.Immunohistochemistry of cryosections of mouse retina incubated with 600-α1 A10 scFv, (A and B), 300 nM biotinylated ZF130H1, negative control scFv (D) or 47 nM of anti-GABAA positive control antibody (C). Streptavidin (SA)-Cy5 or anti-rabbit IgG-Cy5 was used as the secondary detection reagent. Panels A, C and D are images obtained under fluorescent light (Cy5 filter), while panel B shows the image acquired under bright light. Representative images from three independent trials are shown. Scale bar depicts 80 µm. Legend: GCL; Ganglion cell layer, INL; Inner nuclear layer, IPL; inner plexiform layer, ONL; outer nuclear layer, OPL; outer plexiform layer.
Figure 5. Comparison of detection limits of scFv and scFv-Fc.A. Binding specificity of equimolar concentrations of scFv-Fc and scFv A10, to different biotinylated peptides was detected in an ELISA using anti-Flag antibody conjugated to HRP. Signal intensities were measured at 405 nm and error bars indicate standard deviation of duplicate trials. NA, NeutrAvidin™; negative control pep, retinal protein Pep 1 peptide; beta 2, GABAA receptor subunit β2 peptide; rho 1, GABAc receptor subunit ρ pep tide and alpha 1, GABAA receptor subunit α1 peptide. B. Dot blots of varying concentrations of MBP-α1 proteins treated with 10 nM A10 scFv-Fc (top row) and scFv (bottom row). Circles around signal spots indicate pencil markings of protein addition sites. C. Signal intensities normalized to highest signal obtained for each trail are plotted against log of concentration for scFv-Fc and scFv. Error bars depict standard deviations. n = 3.
Figure 1. Binding of phage-expressed scFvs affinity selected with GABA subunit peptides.Equal amounts of biotinylated target peptides or non-target peptide (negative control) were captured on NeutrAvidin™ (NA) coated microtiter plate wells, and after washing the binding of equivalent amounts of phage particles, displaying different scFvs, was monitored by ELISA. A biotinylated anti-Flag antibody was used to normalize the amounts of scFv-displaying phage particles added to each well. Error bars correspond to the standard deviation of triplicate measurements of the optical density of the wells at 405 nm wavelength. A7, G8 and G11 are anti-β2 binders while A10 is the anti-α1 binder.
Accardi,
Antibodies in single-chain format against tumour-associated antigens: present and future applications.
2010, Pubmed
Accardi,
Antibodies in single-chain format against tumour-associated antigens: present and future applications.
2010,
Pubmed Adams,
Generating improved single-chain Fv molecules for tumor targeting.
1999,
Pubmed Albrecht,
Development of anti-MUC1 di-scFvs for molecular targeting of epithelial cancers, such as breast and prostate cancers.
2007,
Pubmed Arap,
Steps toward mapping the human vasculature by phage display.
2002,
Pubmed Bali,
Defining the propofol binding site location on the GABAA receptor.
2004,
Pubmed
,
Xenbase Banghart,
Light-activated ion channels for remote control of neuronal firing.
2004,
Pubmed
,
Xenbase Barbas,
Assembly of combinatorial antibody libraries on phage surfaces: the gene III site.
1991,
Pubmed Binz,
High-affinity binders selected from designed ankyrin repeat protein libraries.
2004,
Pubmed Blazek,
The production and application of single-chain antibody fragments.
2003,
Pubmed Cunningham,
Label-free assays on the BIND system.
2004,
Pubmed Duan,
An efficient method for isolating antibody fragments against small peptides by antibody phage display.
2010,
Pubmed Eggers,
GABA(A), GABA(C) and glycine receptor-mediated inhibition differentially affects light-evoked signalling from mouse retinal rod bipolar cells.
2006,
Pubmed Eisenhardt,
Subtractive single-chain antibody (scFv) phage-display: tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules.
2007,
Pubmed Falk,
Generation of anti-Notch antibodies and their application in blocking Notch signalling in neural stem cells.
2012,
Pubmed Feigenspan,
Electrophysiological properties of mouse horizontal cell GABAA receptors.
2004,
Pubmed Feigenspan,
GABA-gated Cl- channels in the rat retina.
1998,
Pubmed Fletcher,
GABAA and GABAC receptors on mammalian rod bipolar cells.
1998,
Pubmed Greferath,
Localization of GABAA receptors in the rat retina.
1993,
Pubmed Greferath,
GABAA receptor subunits have differential distributions in the rat retina: in situ hybridization and immunohistochemistry.
1995,
Pubmed Grisshammer,
Understanding recombinant expression of membrane proteins.
2006,
Pubmed Grünert,
Immunocytochemical localization of glycine receptors in the mammalian retina.
1993,
Pubmed Gussin,
Quantum dot conjugates of GABA and muscimol: binding to α1β2γ2 and ρ1 GABA(A) receptors.
2013,
Pubmed
,
Xenbase Gussin,
Binding of muscimol-conjugated quantum dots to GABAC receptors.
2006,
Pubmed
,
Xenbase Haidaris,
Recombinant human antibody single chain variable fragments reactive with Candida albicans surface antigens.
2001,
Pubmed Hawlisch,
Site-specific anti-C3a receptor single-chain antibodies selected by differential panning on cellulose sheets.
2001,
Pubmed Heeres,
Identifying modulators of protein-protein interactions using photonic crystal biosensors.
2009,
Pubmed Holliger,
Engineered antibody fragments and the rise of single domains.
2005,
Pubmed Holliger,
"Diabodies": small bivalent and bispecific antibody fragments.
1993,
Pubmed Hötzel,
Efficient production of antibodies against a mammalian integral membrane protein by phage display.
2011,
Pubmed Hust,
The production of a genus-specific recombinant antibody (scFv) using a recombinant potyvirus protease.
2002,
Pubmed Janovjak,
A light-gated, potassium-selective glutamate receptor for the optical inhibition of neuronal firing.
2010,
Pubmed Juárez-González,
Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2.
2005,
Pubmed Junge,
Large-scale production of functional membrane proteins.
2008,
Pubmed Jurd,
General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit.
2003,
Pubmed Kasturirangan,
Targeted hydrolysis of Beta-amyloid with engineered antibody fragment.
2010,
Pubmed Kortt,
Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting.
2001,
Pubmed Koulen,
Selective clustering of GABA(A) and glycine receptors in the mammalian retina.
1996,
Pubmed Li,
Validation of glypican-3-specific scFv isolated from paired display/secretory yeast display library.
2012,
Pubmed Luginbühl,
Directed evolution of an anti-prion protein scFv fragment to an affinity of 1 pM and its structural interpretation.
2006,
Pubmed Lukasiewicz,
A diversity of GABA receptors in the retina.
1998,
Pubmed Macdonald,
GABAA receptor channels.
1994,
Pubmed Mao,
Quikgene: a gene synthesis method integrated with ligation-free cloning.
2011,
Pubmed Maynard,
Antibody engineering.
2000,
Pubmed Milovnik,
Selection and characterization of DARPins specific for the neurotensin receptor 1.
2009,
Pubmed Moghaddam,
Identification of scFv antibody fragments that specifically recognise the heroin metabolite 6-monoacetylmorphine but not morphine.
2003,
Pubmed Mohler,
GABAA-receptors: structural requirements and sites of gene expression in mammalian brain.
1990,
Pubmed Olsen,
GABA A receptors: subtypes provide diversity of function and pharmacology.
2009,
Pubmed Pack,
Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli.
1992,
Pubmed Papanastasiou,
Construction and characterization of a humanized single chain Fv antibody fragment against the main immunogenic region of the acetylcholine receptor.
1999,
Pubmed Pershad,
Drop-out phagemid vector for switching from phage displayed affinity reagents to expression formats.
2011,
Pubmed Peter,
scFv single chain antibody variable fragment as inverse agonist of the beta2-adrenergic receptor.
2003,
Pubmed Pini,
Phage display of antibody fragments.
2000,
Pubmed Qtaishat,
Cysteine-terminated B-domain of Staphylococcus aureus protein A as a scaffold for targeting GABA(A) receptors.
2013,
Pubmed
,
Xenbase Schofield,
Application of phage display to high throughput antibody generation and characterization.
2007,
Pubmed Seeburg,
The GABAA receptor family: molecular and functional diversity.
1990,
Pubmed Sieghart,
Subunit composition, distribution and function of GABA(A) receptor subtypes.
2002,
Pubmed Sigel,
Allosteric modulation by benzodiazepine receptor ligands of the GABAA receptor channel expressed in Xenopus oocytes.
1988,
Pubmed
,
Xenbase Smith,
Strategies for the purification of membrane proteins.
2011,
Pubmed Souriau,
Human antibody fragments specific for the epidermal growth factor receptor selected from large non-immunised phage display libraries.
2004,
Pubmed Stein,
Azo-propofols: photochromic potentiators of GABA(A) receptors.
2012,
Pubmed Steinmeyer,
The art of antibody process development.
2008,
Pubmed Stemmer,
DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution.
1994,
Pubmed Ta,
Enzymatic single-chain antibody tagging: a universal approach to targeted molecular imaging and cell homing in cardiovascular disease.
2011,
Pubmed Thie,
Affinity maturation by phage display.
2009,
Pubmed Tipps,
Identification of novel specific allosteric modulators of the glycine receptor using phage display.
2010,
Pubmed Vaughan,
Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library.
1996,
Pubmed Volgraf,
Allosteric control of an ionotropic glutamate receptor with an optical switch.
2006,
Pubmed Vu,
Activation of membrane receptors by a neurotransmitter conjugate designed for surface attachment.
2005,
Pubmed
,
Xenbase Wafford,
Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.
1993,
Pubmed
,
Xenbase Wagner,
Rationalizing membrane protein overexpression.
2006,
Pubmed Wässle,
Glycine and GABA receptors in the mammalian retina.
1998,
Pubmed Wisden,
GABAA receptor channels: from subunits to functional entities.
1992,
Pubmed Woodward,
Characterization of bicuculline/baclofen-insensitive (rho-like) gamma-aminobutyric acid receptors expressed in Xenopus oocytes. II. Pharmacology of gamma-aminobutyric acidA and gamma-aminobutyric acidB receptor agonists and antagonists.
1993,
Pubmed
,
Xenbase Yang,
Characterization of receptors for glutamate and GABA in retinal neurons.
2004,
Pubmed Yip,
A propofol binding site on mammalian GABAA receptors identified by photolabeling.
2013,
Pubmed Yue,
Robust photoregulation of GABA(A) receptors by allosteric modulation with a propofol analogue.
2012,
Pubmed
,
Xenbase Zucker,
Gamma-aminobutyric acidA receptors on a bistratified amacrine cell type in the rabbit retina.
1998,
Pubmed